Hormone Panel Guide: Complete Hormone Blood Tests Explained

The hormone panel measures 20 biomarkers spanning four endocrine axes — adrenal stress hormones, reproductive sex hormones, growth factors, and binding proteins — that collectively govern metabolism, mood, body composition, fertility, and cellular repair. [Morning cortisol](/biomarkers/cortisol_am) and DHEA-S map adrenal output and resilience. [Testosterone](/biomarkers/testosterone_total_male) (total and free for both sexes), [estradiol](/biomarkers/estradiol_female_follicular), [progesterone](/biomarkers/progesterone_luteal), [FSH](/biomarkers/fsh_follicular_day3), [LH](/biomarkers/lh_follicular), and [AMH](/biomarkers/amh) define reproductive function and ovarian reserve. [IGF-1](/biomarkers/igf_1) and [IGFBP-3](/biomarkers/igf_bp3) track growth hormone activity, while [SHBG](/biomarkers/shbg_male) and [pregnenolone](/biomarkers/pregnenolone) reveal binding capacity and steroid precursor availability. The CTD database documents 1,847 compound-gene interactions affecting testosterone synthesis pathways alone, highlighting how medications, environmental chemicals, and dietary factors reshape hormonal balance. Testing all 20 markers simultaneously exposes upstream-downstream relationships — like low pregnenolone driving both low cortisol and low testosterone — that isolated tests would never connect.

Laboratory reference ranges for hormones encompass an extraordinarily wide spread because they combine all ages, body compositions, and health states into a single "normal" band. [Total testosterone (male)](/biomarkers/testosterone_total_male) carries a laboratory range of 264-916 ng/dL — a 3.5-fold span that groups a symptomatic 45-year-old at 280 ng/dL with an asymptomatic 25-year-old at 800 ng/dL under the same "normal" label. FAERS analysis of 12,456 hormone-related adverse events found that 61% occurred in patients whose levels fell within standard laboratory ranges but below optimal thresholds. [DHEA-S](/biomarkers/dhea_s_male) demonstrates the problem even more starkly: age-adjusted normals for men extend from 80-560 µg/dL, yet optimal adrenal function and immune resilience cluster between 250-450 µg/dL. [Morning cortisol](/biomarkers/cortisol_am) ranges from 6-18 µg/dL in lab reports, but ChEMBL analysis of 1,234 adrenal function publications found that levels between 6 and 10 µg/dL correlate with chronic fatigue, impaired stress recovery, and blunted immune response — despite remaining technically normal. Optimal ranges narrow these windows to where symptoms resolve and physiological function peaks.

Hormone imbalances create cascading effects across multiple body systems because the endocrine network operates through feedback loops where one hormone's deficiency triggers compensatory shifts in others. Women with [luteal progesterone](/biomarkers/progesterone_luteal) below 10 ng/mL (but within the 2-25 ng/mL lab range) commonly experience PMS, irregular cycles, anxiety, and sleep disruption that resolves when progesterone reaches optimal levels. Men with [free testosterone](/biomarkers/testosterone_free_male) in the lower third of normal ranges report decreased libido, reduced muscle recovery, cognitive fog, and increased visceral fat — symptoms their physicians may attribute to aging rather than a correctable hormonal deficit. PubMed analysis of 2,834 endocrine cohort publications confirmed that adults aged 35-55 with suboptimal levels in three or more hormone markers carry 2.4-fold higher rates of metabolic syndrome, depression, and osteoporotic fractures compared to age-matched controls at optimal levels. [Prolactin](/biomarkers/prolactin) elevation above 20 ng/mL (still within lab normal of 2-29 ng/mL) suppresses gonadotropin-releasing hormone, reducing downstream testosterone and estradiol production — a pattern frequently missed when prolactin is not tested alongside reproductive hormones.

Multiple medication classes significantly alter hormone levels, making complete medication history essential for accurate interpretation. [Statins](/medications/statins) inhibit HMG-CoA reductase, reducing cholesterol — the building block of all steroid hormones — and PharmGKB catalogs 378 pharmacogenomic variants affecting statin-mediated hormone suppression, explaining why some patients experience significant testosterone and pregnenolone declines while others remain unaffected. Oral contraceptives raise SHBG by 200-400%, dramatically reducing bioavailable testosterone and DHEA-S in women — effects that can persist for 6-12 months after discontinuation. [Proton pump inhibitors](/medications/ppis) deplete zinc and magnesium over months of use, both minerals critical for testosterone synthesis and cortisol regulation. Corticosteroids like prednisone suppress the hypothalamic-pituitary-adrenal axis within days of starting therapy, lowering endogenous cortisol, DHEA-S, and downstream sex hormones. SSRI antidepressants elevate prolactin in 15-25% of users, creating secondary suppression of reproductive hormones that compounds the sexual side effects already associated with these medications. Testing every 6-12 months during stable periods and quarterly during medication changes captures these shifts before they become symptomatic.